TY - JOUR
T1 - The GATA-4 transcription factor transactivates the cardiac-specific troponin C promoter-enhancer in non-muscle cells
AU - Ip, H. S.
AU - Wilson, D. B.
AU - Heikinheimo, M.
AU - Leiden, J. M.
AU - Parmacek, M. S.
AU - Kessler- Icekson, G.
PY - 1995
Y1 - 1995
N2 - The unique contractile phenotype of cardiac myocytes is determined by the expression of a set of cardiac-specific genes. By analogy to other mammalian developmental systems, it is likely that the coordinate expression of cardiac genes is controlled by lineage-specific transcription factors that interact with promoter and enhancer elements in the transcriptional regulatory regions of these genes. Here, we demonstrate that the slow/cardiac-specific troponin C (cTnC) enhancer contains a specific binding site for the lineage- restricted, zinc finger transcription factor, GATA-4 and that GATA-4 mRNA and protein is expressed in cardiac myocytes. In addition, GATA-4 binding sites were identified in several previously characterized cardiac-specific transcriptional regulatory elements. The cTnC GATA-4 binding site is required for transcriptional enhancer activity in primary cardiac myocytes. Moreover, the cTnC enhancer can be transactivated by overexpression of GATA-4 in non- cardiac muscle cells such as NIH 3T3 cells. Taken together, these results are consistent with a model in which GATA-4 functions to direct tissue-specific gene expression during mammalian cardiac development.
AB - The unique contractile phenotype of cardiac myocytes is determined by the expression of a set of cardiac-specific genes. By analogy to other mammalian developmental systems, it is likely that the coordinate expression of cardiac genes is controlled by lineage-specific transcription factors that interact with promoter and enhancer elements in the transcriptional regulatory regions of these genes. Here, we demonstrate that the slow/cardiac-specific troponin C (cTnC) enhancer contains a specific binding site for the lineage- restricted, zinc finger transcription factor, GATA-4 and that GATA-4 mRNA and protein is expressed in cardiac myocytes. In addition, GATA-4 binding sites were identified in several previously characterized cardiac-specific transcriptional regulatory elements. The cTnC GATA-4 binding site is required for transcriptional enhancer activity in primary cardiac myocytes. Moreover, the cTnC enhancer can be transactivated by overexpression of GATA-4 in non- cardiac muscle cells such as NIH 3T3 cells. Taken together, these results are consistent with a model in which GATA-4 functions to direct tissue-specific gene expression during mammalian cardiac development.
UR - http://www.scopus.com/inward/record.url?scp=0029160364&partnerID=8YFLogxK
U2 - 10.1007/978-1-4615-1893-8_13
DO - 10.1007/978-1-4615-1893-8_13
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 8540389
AN - SCOPUS:0029160364
SN - 0065-2598
VL - 382
SP - 117
EP - 124
JO - Advances in Experimental Medicine and Biology
JF - Advances in Experimental Medicine and Biology
ER -